Neurological Intensive Care for Acute Spinal Cord Injury Patients
نویسندگان
چکیده
منابع مشابه
Spinal cord injury: acute care management.
This article has been subjected to double blind peer review The first two articles in this series described the anatomy and physiology of the vertebral column and spinal cord, and examined the aetiology and pathophysiology of spinal cord injuries (Sheerin 2004, 2005). These provide a basis for understanding the presentation and management of spinal cord injuries. It is difficult to be prescript...
متن کاملNew avenues for reducing intensive care needs in patients with chronic spinal cord injury
Relatively soon after their accident, patients suffering a spinal cord injury (SCI) begin generally experiencing the development of significant, often life-threatening secondary complications. Many of which are associated with chronic physical inactivity-related immune function problems and increasing susceptibility to infection that repeatedly requires intensive care treatment. Therapies capab...
متن کاملNeurological Prognosis of Acute Cervical Spinal Cord Injury Patients Requiring Catecholamine Administration
Study Design: Retrospective cohort study using aggregated data from our institute. Objective: To examine the effects of hypotension requiring catecholamine (dopamine and epinephrine) administration on neurologic recovery in acute cervical spinal cord injury (SCI). Summary of Background Data: Following spinal cord injury, traumatic blood loss and spinal shock can occur causing low blood pressure...
متن کاملTransforming care for patients with spinal cord injury in Haiti.
Patients with spinal cord injury in Haiti previously had a poor prognosis. This article features a case study showing how care was transformed after the earthquake in 2010 by providing simple bladder care.
متن کاملPharmacological Therapy for Acute Spinal Cord Injury.
• Administration of methylprednisolone (MP) for the treatment of acute spinal cord injury (SCI) is not recommended. Clinicians considering MP therapy should bear in mind that the drug is not Food and Drug Administration (FDA) approved for this application. There is no Class I or Class II medical evidence supporting the clinical benefit of MP in the treatment of acute SCI. Scattered reports of C...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Neurointensive Care
سال: 2018
ISSN: 2635-5280
DOI: 10.32587/jnic.2018.00045